Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_05-cv-05153/USCOURTS-cand-3_05-cv-05153-0/pdf.json

Parties Involved:
Eli Lilly and Company
Defendant
Christopher Parlato
Plaintiff
Arabella Stoffel
Plaintiff

Document Text:

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 1

 In their proposed order, plaintiffs begin one sentence with the following phrase: “In

the event the case is not transferred to the Honorable Claudia Wilken and/or the Eastern

District of New York[.]” Plaintiffs make no reference to Judge Wilken in their Case

United States District Court

For the Northern District of California

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

CHRISTOPHER PARLATO and ARABELLA

STOFFEL,

Plaintiffs,

 v.

ELI LILLY AND COMPANY,

Defendant.

 /

No. C-05-5153 MMC

ORDER CONTINUING CASE

MANAGEMENT CONFERENCE;

DIRECTING PLAINTIFFS TO FILE

STATEMENT RE: MDL

Before the Court is plaintiffs’ Case Management Conference Statement, filed

March 10, 2006, by which plaintiffs seek to continue the March 17, 2006 case management

conference in the instant action by approximately 120 days. Plaintiffs state that a

continuance is necessary because they anticipate the instant action will be transferred to

the Eastern District of New York for inclusion in MDL No. 1596, In re Zyprexa Products

Liability Litigation, and because they have not yet served the defendant.

There is no indication in the docket or in plaintiffs’ statement that plaintiffs have

taken any steps to notify the Judicial Panel on Multidistrict Litigation of the existence of the

instant action.1

 Consequently, plaintiffs have not shown good cause for the requested

Case 3:05-cv-05153-MMC Document 5 Filed 03/14/06 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Management Conference Statement, let alone provide any indication that any

administrative motion has been filed with respect to whether the instant action should be

related to a case pending before Judge Wilken. See Civil L.R. 3-12(b).

2

120-day continuance. Nevertheless, because the instant action was filed December 13,

2005, and the deadline to serve defendant is April 12, 2006, see Fed. R. Civ. P. 4(m), the

Court will continue the case management conference to May 12, 2006 at 10:30 a.m.

Accordingly,

1. The March 17, 2006 case management conference is hereby continued to

May 12, 2006 at 10:30 a.m. A joint case management statement shall be filed no later than

May 5, 2006. The deadline to serve the defendant, pursuant to Rule 4(m) of the Federal

Rules of Civil Procedure, remains in effect.

2. No later than March 24, 2006, plaintiffs shall file a statement with the Court

identifying the steps plaintiffs have taken to date to transfer the instant action to the Eastern

District of New York for inclusion in MDL No. 1596, In re Zyprexa Liability Litigation, and/or

to have the instant action related to any other action.

IT IS SO ORDERED.

Dated: March 14, 2006 

MAXINE M. CHESNEY

United States District Judge

Case 3:05-cv-05153-MMC Document 5 Filed 03/14/06 Page 2 of 2